Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Boston Scientific Corporation (BSX) vs Indonesia Energy Corporation Limited (INDO) Price & Performance

Boston Scientific CorporationTrade
Indonesia Energy Corporation LimitedTrade

Price performance (Past 24H)

Key statistics

Boston Scientific Corporation vs Indonesia Energy Corporation Limited — how do they compare? Boston Scientific Corporation trades at $51.56 (market cap $74.19B), while Indonesia Energy Corporation Limited trades at $2.97 (market cap $45.55M). The key difference: Boston Scientific Corporation is far larger — about 1628.8× Indonesia Energy Corporation Limited's market cap. Which is the better fit depends on your goals.

BSXINDO
Market Cap
$74.19B$45.55M
Sector
HealthEnergy
52-Week High
$108.14$6.74
52-Week Low
$42.63$2.49
Enterprise Value
$86.27B$40.92M

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Boston Scientific Corporation

Boston Scientific (BSX) trades at $51.27, up 1.6% with strong technical momentum and bullish moving averages. The company delivered three consecutive quarterly EPS beats in 2026, with Q2 EPS of $0.86 exceeding expectations. Revenue grew to $20.07B in 2025 with a 14.4% net margin, while analyst consensus shows 86% buy ratings with a $67.21 price target. Recent insider buying by the CEO and director signals confidence despite near-term guidance challenges.

BSX presents attractive valuation with 44% upside to consensus target, supported by strong fundamentals and institutional support. Key risks include competitive pressures in WATCHMAN and electrophysiology segments, along with elevated RSI levels suggesting potential near-term consolidation. The long-term growth trajectory remains intact with 2026 revenue projected at $21B and 17.5% margins.

Indonesia Energy Corporation Limited

INDO trades at $2.97, up 1.71% today, with a bullish technical signal supported by moving averages. The company reported a net loss of $5 million on $2 million revenue in 2025, resulting in negative profit margins. Recent news highlights operational progress with the commencement of drilling at the K-29 well in Indonesia. Analyst consensus is unanimously bullish with three buy ratings.

The outlook hinges on successful well development driving future revenue growth, but high valuation multiples and persistent losses pose significant risks. Investors face volatility from execution challenges in oil and gas exploration, though positive analyst sentiment suggests potential upside if operational milestones are met.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About Boston Scientific Corporation

Boston Scientific produces less invasive medical devices that are inserted into the human body through small openings or cuts. It manufactures products for use in angioplasty, blood clot filtration, cardiac rhythm management, catheter-directed ultrasound imaging, structural heart disease, upper gastrointestinal tract diagnostics, interventional oncology, and treatment of incontinence. The firm markets its devices to healthcare professionals and institutions globally. Foreign sales account for nearly half of the firm's total sales.

Read more on BSX

About Indonesia Energy Corporation Limited

Indonesia Energy is an oil and gas exploration and production company. It focuses on identifying and developing energy resources in Indonesia, primarily through its Kruh and Citarum blocks.

Read more on INDO